The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer
暂无分享,去创建一个
A. Hartmann | H. Taubert | S. Wach | B. Wullich | H. Holzhausen | T. Greither | P. Fornara | R. Stöhr | G. Theil | O. Al-Janabi | K. Weigelt | K. Fischer | E. Nolte | Marios Marcou | Verena Huppert